Document is current
Any future updates will be listed below
-
Authors
Weening, Eerde H.
Al-Mubarak, Ali A.
Dokter, Martin M.
Dickstein, Kenneth
Lang, Chim C.
Ng, Leong L.
Metra, Marco
van Veldhuisen, Dirk J.
Touw, Daan J.
de Boer, Rudolf A.
Gansevoort, Ron T.
Voors, Adriaan A.
Bakker, Stephan J. L.
van der Meer, Peter
Bomer, Nils
-
Funding
Funding for this research was provided by:
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (OCENW.KLEIN.483)
- License Information
-
More Information
Article History
Received: 6 October 2022
Accepted: 21 December 2022
First Online: 12 January 2023
Declarations
:
: BIOSTAT-CHF is a multicenter prospective study with patients from 69 centers in 11 European countries. Institutional Review Board approval was obtained in all countries and complied with the Declaration of Helsinki. The PREVEND Study was approved by the local medical ethics committee and conducted in accordance with guidelines of the Declaration of Helsinki.
: Not applicable.
: The authors declare that they have no competing interests.
